Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure
- 1 April 2016
- journal article
- review article
- Published by Microbiology Society in Journal of General Virology
- Vol. 97 (4), 825-838
- https://doi.org/10.1099/jgv.0.000401
Abstract
A complex interaction exists between elements of the host innate immune system and viral pathogens. It is essential that the host mount a robust immune response during virus infection and effectively resolve inflammation once the pathogen has been eliminated. Members of the NBD-LRR (Nod-like Receptor; NLR) family of cytosolic pattern recognition receptors are essential components of these immunological processes and have diverse functions in the host antiviral immune response. The NLRs can be sub-grouped based on their general function. The inflammasome forming sub-group of NLRs are the best characterized family members and several have been found to modulate the maturation of IL-1β and IL-18 following virus exposure. However, the members of the regulatory NLR sub-groups are significantly less characterized. These NLRs uniquely function to modulate signaling pathways initiated by other families of pattern recognition receptors, such as Toll-like Receptors (TLRs) and/or Rig-I-like Helicase Receptors (RLRs). Regulatory NLRs that augment pro-inflammatory pathways include NOD1 and NOD2, which have been shown to form a multi-protein complex termed the NODosome that significantly modulates interferon and NF-κB signaling following viral infection. Conversely, a second sub-group of regulatory NLRs functions to negatively regulate inflammation. These inhibitory NLRs include NLRX1, NLRP12, and NLRC3, which have been shown to interact with TRAF molecules and various kinases to modulate diverse cellular processes. Targeting NLR signaling following infection with virus represents a novel and promising therapeutic strategy. However, significant effort is still required to translate the current understanding of NLR biology into effective therapies.Keywords
This publication has 108 references indexed in Scilit:
- NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB SignalingImmunity, 2012
- Structure and Functional Characterization of the RNA-Binding Element of the NLRX1 Innate Immune ModulatorImmunity, 2012
- Expression, purification, and characterization of recombinant NOD1 (NLRC1): A NLR family memberJournal of Biotechnology, 2012
- NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling PathwaysImmunity, 2011
- NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKKImmunity, 2011
- Viral Infection Augments Nod1/2 Signaling to Potentiate Lethality Associated with Secondary Bacterial InfectionsCell Host & Microbe, 2011
- The InflammasomesCell, 2010
- Autophagy, antiviral immunity, and viral countermeasuresBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Modulation of adaptive immunity by different adjuvant–antigen combinations in mice lacking Nod2Vaccine, 2008
- The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMOCurrent Biology, 2004